Exchange: NYSEMkt·Updated 05:42 AM EDT
AEON logo

AEON AEON Biopharma Inc. - Ordinary Shares - Class A

$0.2486
$0.0061
(2.52%)
Pre-Market
Prev Close $0.2425
Mkt Cap$12.1M
Vol29,755.00

About AEON

AEON Biopharma, Inc. is a biopharmaceutical company, which engages in the business of developing proprietary botulinum toxin complex, ABP-450 injection, for debilitating medical conditions. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Irvine, CA.
31

Bearish Sentiment

How do you feel about AEON?

Advertisement|Remove ads.